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This dissertation thesis deals with the evaluation of biocompatibility and 
osseointegration of nanostructured titanium materials used for dental implants. Bulk 
material topography and surface modification of titanium are currently of intense 
research mainly due to the significant impact on biocompatibility and improvement 
of osseointegration of dental implants.  
In the theoretical part are described types of titanium material and different methods 
of its surface modification. In vitro and in vivo biocompatibility and osseointegration 
tests are described as well. 
The experimental work consists of two parts of experiments. In the first experiment, we 
examined how grain size of nanostructured titanium material influences the behaviour 
of fibroblastic as well as osteoblastic cells growth on its surface. The experimentally 
obtained data were statistically analysed and discussed. Grain size was proven to be an 
important factor that influenced not only the strength of material but also its interactions 
with cells.  
The second experiment describes current methods used in the experimental evaluation 
of osseointegration of dental implants. The results of histological staining methods are 
illustrated and compared. A standardized and reproducible technique for stereological 
quantification of bone-implant contact is proposed and demonstrated. Surface 
modifications were verified to play a very important role in biocompatibility and 
osseointegration. Surface roughness significantly increases the contact area between 
implant and peri-implant bone. Practical recommendations for the experiment, 
harvesting of samples, tissue processing and quantitative histological evaluation are 
provided. 
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Tato disertační práce se zabývá hodnocením biokompatibility a oseointegrace materiálů 
z nanostrukturovaného titanu používaných jako dentální implantáty. Titanové dentální 
implantáty a jejich povrchové úpravy jsou v současnosti intenzivně studovány pro jejich 
pozitivní vliv na biokompatibilitu a oseointegraci. 
V teoretické části práce jsou popsány různé typy titanových materiálů a různé druhy 
povrchových úprav. Rovněž jsou popsány in vitro a in vivo metody testování 
biokompatibility a oseointegrace. 
Experimentální část práce tvoří dvě skupiny experimentů. V první části je zjišťován 
vliv velikosti zrn na povrchu nanostrukturovaného titanu na chování a růst buněčných 
kultur fibroblastů a osteoblastů. Získaná experimentální data jsou statisticky 
analyzována a diskutována. Velikost zrn se jeví jako důležitý faktor, který ovlivňuje 
nejen pevnost materiálu, ale také interakci s buňkami. 
Druhá část experimentu se zabývá metodami hodnocení oseointegrace dentálních 
implantátů. Jsou zde uvedeny a srovnány výsledky metod histologického barvení a je 
navržena reprodukovatelná metoda stereologické kvantifikace kontaktu kost-implantát. 
Bylo potvrzeno, že povrchové modifikace hrají velmi důležitou roli v biokompatibilitě a 
oseointegraci. Drsnost povrchu významně zvyšuje kontaktní plochu mezi implantátem a 
přiléhající kostí. V závěru jsou navržena doporučení pro správný sběr vzorků, jejich 
zpracování a kvantitativní histologické hodnocení. 
 
Klíčová slova: biokompatibilita, oseointegrace, titan, nanotopografie, dentální 
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List of Abbreviations 
ASTM American society for testing and materials 
ATCC American type culture collection 
BC Bone contact 
BIC Bone implant contact 
BMP   Bone morphogenetic protein 
CaP Calcium phosphate 
CCL153 Cellosaurus cell line of human foetal lung fibroblasts 
CMFDA 5-chloromethylfluorescein diacetate 
cpTi Commercially pure titanium 
DMSO Dimethyl sulfoxide 
ECAP Equal channel angular pressing 
ECM Extracellular matrix 
EDTA Ethylenediaminetetraacetic acid 
FAK Focal adhesion kinase 
FBS Foetal bovine serum 
FGF Fibroblast growth factor 
HA  Hydroxyapatite 
HBD Human beta defensin 
HF  Hydrofluoric acid 
HFL1 Human foetal lung fibroblasts 
hFOB Human foetal osteoblast cell line 
HMG-CoA  5-hydroxy-3-methylglutaryl-coenzyme A 
HTC High throughput screening 
hVIN-1 Anti-human vinculin antibody 
ICC Immunocytochemistry 
IFN-γ  Interferon gamma 
IL Interface length 
ILK Integrin-linked kinase 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NAD
+
 Nicotinamide adenine dinucleotide  
NADH Nicotinamide adenine dinucleotide (reduced form) 
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nHA Nanoscale hydroxyapatite 
nTi Nanostructured titanium 
PDGF Platelet-derived growth factor 
RGD Arginylglycylaspartic acid; tripeptide composed of L-arginine, 
glycine, and L-aspartic acid 
SDS Sodium dodecyl sulfate (synonymously sodium lauryl sulfate, SLS) 
SEM Scanning electron microscope 
SLA Sandblast, large-grit, and acid etching 
SPD Severe plastic deformation  
Src Sarcoma proto-oncogene, non-receptor tyrosine kinase 
TGF-β  Transforming growth factor beta 
TNF-α   Tumour necrosis factor alpha 
TRITC Tetramethylrhodamine  
VEGF   Vascular endothelial growth factor 
% v/v Volume per volume 







The biocompatibility of synthetic substances (biomaterials) used for the replacement 
of biological tissues have always been a high-priority concern within the health care 
disciplines, including dentistry. 
The history of the evolution of dental implants is an amazing journey through 
time. Since the beginning of mankind, humans have used dental implants of 
various kinds to replace missing teeth. In 2,500 BC, the Egyptians stabilized teeth 
with the gold wire ligature, about 500 BC, the Etruscans restored oral function 
with soldered gold bands and oxen bones, around 300 AD, the Phoenicians used 
teeth carved out of ivory and stabilized by gold wire in fixed bridge. Until the 
beginning of the 19
th
 century innumerable substances were used as implants.
1
 
However, the real development of modern dental implantology began in 1952 with 
first experiments of Professor Per-Ingvar Brånemark. He developed a screw-shaped 
cylindrical implant designed from pure titanium. After implantation, he observed 
bone growing in such close proximity to the titanium implant that effectively 
adhered to the metal. Based on these observations, he and his colleagues later 
defined the concept of osseointegration as a direct and stable anchorage of an 
implant through the formation of bony tissue without the growth of  fibrous tissue 
at the bone-implant interface.
2
 
For osseointegration of dental implants, the suitable surface modifications, shape and 
materials are critical.
3 
To be considered successful, an osseointegrated dental implant 





1.1 Classification  of  Implantable  Materials 
in  Dentistry 
Materials used for the fabrication of dental implants can be divided in two different 
ways depending on their chemical or biological characteristics. 
From a basic chemical point of view, dental implants can be categorised into one of the 
following three groups:  
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1) metals,  
2) ceramics, and  
3) polymers.  
 
In addition, biomaterials can be classified based on the type of biologic response they 
elicit when implanted and the long-term interaction that develops with the host tissue. 
Three major types of biodynamic activity have been reported:  
1) biotolerant,  
2) bioinert, and  
3) bioactive.5,6 
 
Biotolerant materials are those that are not necessarily rejected when implanted into 
living tissue, but are surrounded by a fibrous layer in the form of a capsule.  
Bioinert materials allow close apposition of bone on their surface, leading to contact 
osteogenesis. 
Bioactive materials also allow the formation of new bone onto their surface, but ion 
exchange with host tissue leads to the formation of a chemical bond along the interface 
(bonding osteogenesis).  
Bioinert and bioactive materials are also called osteoconductive, meaning that they can 






Metals Ceramics Polymers 







Cobalt-chromium alloys Polyamide 
Stainless steel Polymethylmethacrylate 
Zirconium Polytetrafluoroethylene 
Niobium Polyurethane 
Tantalum   
Bioinert Commercially pure titanium Aluminium oxide   
  Titanium alloy (Ti-6Al-4V) Zirconium oxide 



























Table 1: Classification of dental implant materials.7 
 
1.2 Titanium and Its Alloys 
Since 1970, a number of new implant materials and designs have been developed, 
including the use of polymers, porcelain, high-density aluminium oxide (Alumina), 
bioactive glass (Bioglass) and carbon materials. Although nowadays, the most 
frequently used implant material is titanium which has become the gold standard in 
implant dentistry.  
Titanium and its alloys are used in dentistry as prosthetic appliances thank to their 
unique combination of chemical, physical and biological properties. The American 
Society for Testing and Materials (ASTM International) recognizes different grades of 
commercially pure titanium (cpTi), and titanium alloys (Ti-6Al-4V, Ti-5Al-1.5B, 
Ti-6Al-7Nb, etc.). Clinically two forms of titanium have received the most 









1.2.1 Commercially Pure Titanium 
Commercially pure titanium can be found in four different grades (see Table 2), which 
vary mainly in the content of oxygen.  
ASTM Grade 1: In comparison to other grades, ASTM Grade 1 is chemically the purest 
one which makes the allergenic risk extremely low. It has the lowest mechanical 
strength among all grades but, at the same time, the highest formability. Alike the other 
grades, its corrosion resistance is excellent which is crucial for biocompatibility. 
ASTM Grade 2: Grade 2 of titanium has very similar general properties like Grade 1. 
The main difference is in better mechanical resistance due to the higher content of 
interstitial elements iron and oxygen. 
ASTM Grade 3: Grade 3 has the same ratio of iron; however, it has a higher content of 
nitrogen and oxygen. Mechanical properties are better in comparison to the Grade 2. 
ASTM Grade 4: Grade 4 contains the most interstitial elements among all the grades – 
the content of iron is up to 0.5 % and content of oxygen up to 0.4 %. Mechanical 
properties as well as corrosion resistance are outstanding. 
ASTM Grade Ti [%] Femax [%] Omax [%] Hmax [%] Cmax [%] Nmax [%] 
Grade 1 99,5 0,20 0,18 0,015 0,08 0,03 
Grade 2 99,2 0,30 0,25 0,015 0,08 0,03 
Grade 3 99,1 0,30 0,35 0,015 0,08 0,05 
Grade 4 99,0 0,50 0,40 0,015 0,08 0,05 
 
Table 2: Grades of cpTi. 
 
1.2.2 Titanium Alloys 
Titanium can be mixed with other chemical element(s) in order to improve its 
properties, such as strength, high temperature performance, creep resistance, response to 
ageing, heat treatments and formability.  
The most commonly used alloys for dental implants contain 6% aluminium and 
4% vanadium (Ti-6Al-4V). Aluminium serves to increase the strength and decrease the 





Among other commonly elements used for titanium alloys belong, palladium, copper, 
zirconium, niobium, boron, molybdenum, tin and others. Potentially allergenic metal 
additives represent a significant disadvantage in comparison to cpTi. 
 
1.2.3 Nanostructured Titanium 
An important direction intensively developed in recent years is the investigation 
of mechanical properties of nanostructured materials. Nanomaterials are generally 
materials with grain size of 10
-9
 m. The formation of nanostructures in metals leads to 
higher strength but the costs remain very high (about 10 times more in comparison to 
cpTi). There is great interest in the processing of bulk, fully dense nanostructured metals 
and alloys. The fabrication of such materials based on severe plastic deformation (SPD) 
methods seems very interesting and useful. The first developments and investigation of 
nanostructured materials processed using SPD methods were carried out by Valiev et al. 
more than three decades ago.
12-14 
A promising and efficient method for the production of bulk ultrafine grained or 
nanostructured material is equal channel angular pressing (ECAP). The ECAP method 
involves the deformation of massive billets via pure shear followed by another possible 
deformation. The method was further developed and applied as an SPD method for 
processing structures with submicron and nanometric grain sizes. Nanostructured 





Figure 2: Principle of ECAP method17 
It is known that nanostructuring of material changes its biological properties compared 
with material of the same chemical composition, but the mechanism of this phenomenon 
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has not yet been clarified.
18
 The first evidence of such an effect was provided by 
Webster et al. in 1999, who found that osteoblast adhesion and bone formation 
significantly increased on nanostructured titanium surface compared with conventional 
titanium.
19
 Since that time many in vitro as well as in vivo studies have investigated the 
impact of the nanostructured surface on the behaviour of cells and provide evidence that 
key biological processes, such as proliferation, gene expression, and initial protein 
adsorption that control such events, can be easily manipulated by modifying the 
nanotopography of implants.
20-23
 It has also been proven that cells sense and react to 




1.3 Implant Surface Modifications 
Surface treatments are normally carried out to modify yet maintain desirable properties 
of the substrate materials. The surface area can be increased remarkably by using proper 
modification techniques, either by addition or subtraction procedures. A surface 
treatment can also be classified into mechanical, chemical, and physical methods. In 
dental implant, the surface treatment is used to modify the surface topography and 
energy in order to improve wettability, increase cell proliferation and growth, and 
accelerate osseointegration process.  
The interfacial interactions between recipient tissues and implanted material are limited 
to the surface layer of the implant and a few nanometres into the living tissues. Hence, 
the quality of dental implant depends on the properties of the surface.
26
 
For example, osteoblasts have higher probability to adhere to a rough titanium surface 
while fibroblasts and epithelial cells adhere mainly to very smooth surfaces.
27,28
 
However, it has been shown that roughness may play an important role in the 
percentage of bone apposition as well as in the velocity of apposition. Roughness or 
acid conditioning of the surfaces can therefore significantly improve shear strength.  
Besides optimizing the procedure, these surface characteristics may allow an earlier 
loading of the implant and extend the indications for implants in low-density alveolar 




1.3.1  Laser Treatment 
The laser beam radiates electromagnetic energy that interacts with the titanium, taking it 
from a solid state to a plasma state. The extremely concentrated energy pulses of the 
laser allow micro-fabrication of the implant surface without any dangerous effects, such 
as thermal changes of material properties that can induce micro-fractures or alteration 
of the metal structure. This controlled micro-ablation is obtained using a low power 
setting. An important goal of laser treatment of an implant surface is to produce a 
surface with thousands of hemispheric pores for bone apposition.
29,30
 




1.3.2  Acid Etching 
In acid etching, the use of acids on metal surfaces is not only to clean the surface but 
also to modify the roughness. A strong acid like hydrofluoric (HF), nitric (HNO3), and 
sulphuric (H2SO4) or a combination of these acids is commonly used in this technique. 




Acid etching of titanium is of particular interest because it creates a micro-textured 
surface (a fine rough surface with micro pits of 1-3 μm and larger pits of approximately 
6-10 μm) that appears to enhance early endosseous integration and the stability of the 
implant.
33
 This may be related to the changes in surface roughness and chemical 
composition. 
 
1.3.3  Plasma Spray Coating 
A coating produces a rough implant surface that significantly improves the implant 
anchorage in the bone. Plasma coating works by blowing an inert gas through an intense 
electric arc. Down the arc, the coating material is introduced in the form of an extremely 
hot gas. The inert gas is broken into ions and electrons; this state is known as plasma. 
The titanium hydride (coating material) decomposes in the gas stream and forms 
droplets of molten metal that are projected onto the implant surface to build up a 
coating. The layer is typically 20-30 μm thick with a roughness of approximately 
15 μm. Gases in titanium harden the metal, which is an advantageous enhancement for 
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the surface of an implant.
34
 The bond strength between the porous plasma layer and the 
substrate is limited, but excessive treatment, such as exposure to an ultrasound source, is 
needed to cause this bond to fail. Titanium implants with this type of coating have an 
average BIC in cancellous bone of nearly 40 %, which is significantly higher than for 





1.3.4  Sand Blasting  
Sand blasting roughens the surface of the implant and achieves both micro-retentive 
topography and increased surface area.
36,37
 A sand-blasting treatment consists 
of the mechanical abrasion of surfaces using particles shot against the implant. The 
treatment produces a surface with a roughness that depends on the size, shape and 
kinetic energy of the particles. However, this increased roughness may reduce the 
endurance properties of metals.
38
 Studies by Wennerberg et al.
39,40
 demonstrated an 
optimal blasting particles of 75 μm, which made implant more resistant to torque and 
gave it greater bone-to-metal contact than did small (25 μm) or coarse (250 μm) 
particles. The optimal surface had an average height deviation of approximately 1.5 μm, 
resulting in a surface enlargement of 50 %. An average BIC around titanium sand-
blasted implants is comparable to that observed around plasma-sprayed surfaces. 
 
1.3.5  Sandblast, Large-Grit, and Acid Etching (SLA) 
SLA is used to induce surface erosion by applying a strong acid onto the blasted 
surface. This treatment combines blasting with large-grit sand particles and acid etching 
sequentially to obtain macroroughness and micropits to increase the surface roughness 
as well as osseointegration. 
Kim et al. observed that human osteoblasts grow well on the SLA surface which 
provides space for cell adhesion and proliferation. SLA surface possessed wide cavities 
(from 5 μm to 20 μm in diameter) and micropits (from ~0.5 μm to 3 μm in diameter), 






1.3.6  Anodic Oxidation 
In anodic oxidation, the implant is exposed to an electric arc with the implant serving as 
an anode. The implant surface is electrochemically modified to increase the thickness of 
the TiO2 layer from 17-200 nm in conventional titanium implants to 600-1,000 nm. 
Thus, a porous surface microstructure with pore sizes of about 1.3-2.0 mm
2
, a porosity 
of roughly 20 %, and a moderate degree of surface roughness of Sa = 1 μm is generated. 
Accordingly, this type of implant surface has also been referred to as titanium porous 
oxide or anodized titanium surface implant.  
Nanostructured titanium surfaces generated by anodic oxidation have been shown to 




SURFACE TREATMENT IMPLANT SYSTEM / SURFACE 
Acid-etched 
Etching with strong acids increases the surface roughness 
and the surface area of titanium implants. 
BIOMET 3i OSSEOTITE and NanoTite 
Anodized 
This electrochemical process thickens and roughens the 
titanium oxide layer on the surface of implants. 
Nobel Biocare TiUnite 
Blasted 
Particles are projected through a nozzle at a high velocity 
onto the implant. Various materials, such as titanium 
dioxide, aluminium dioxide and hydroxyapatite (HA) are 
often used. 
DENTSPLY Implants ASTRA TECH 
TiOblast, Zimmer Dental MTX, Inclusive 
Tapered Implants 
Blasted and acid-washed / etched 
Implants undergo a blasting process. Afterward, the 
surface is either washed with non-etching acid or etched 
with strong acids. 
CAMLOG Promote, DENTSPLY Implants 
FRIALIT and FRIADENT plus, 
Straumann SLA 
Hydroxyapatite (HA) 
HA is an osteoconductive material that has the ability to 
form a strong bond between the bone and implant. 
Implant Direct (various), Zimmer Dental 
MP-1 
Laser ablation 
High-intensity pulses of a laser beam strike a protective 
layer that coats the metallic surface. As a result, implants 





Powdery forms of titanium are injected into a plasma 
torch at elevated temperatures. 
Straumann ITI titanium plasma-sprayed 
(TPS) 
Table 3: Overview of implants and their respective surface treatments.43 
 
1.3.7  Hydrophilic Implant Surface 
An important modification is the improvement of the wettability of implant surfaces due 
to the biological implications of hydrophilicity, from the initial contact between an 
implant surface and host interface, which involves interactions with water and ions via 
conditioning by the formation of protein-rich films, up to the level of cellular 
interactions. The general idea is that when wettability is increased, biocompatibility is 
enhanced, promoting interactions between an implant surface and the biological 
environment, allowing for the activation of cellular activity most likely modulated by 
the energy of implant surface. 
Conventional surfaces are kept dry and exposed to air, making them hydrophobic due to 
the adsorption of carbon and the hydrocarbons present in the air and reducing the 
wetting of the implant by the surrounding biological environment; this process makes it 
difficult for proteins to be adsorbed and for cellular responses to be induced. One of the 
principal strategies for preventing a decrease in the surface energy of titanium implants 
is the liquid isolation of the surface of TiO2 not contaminated by the atmosphere. 
Compared to conventional surfaces, these modified surfaces favour the adsorption of 
proteins and are able to promote the activation of osteoblasts toward a more osteogenic 
phenotype. These phenomena suggest that the increased bone formation observed on the 
modified surface of these implants should be due to the stimulating effect of high 
surface energy on osteoblasts. Previous studies have shown that a hydrophilic surface is 






Figure 3: Drop of water on hydrophobic SLA surface (a) and on hydrophilic modSLA 
surface (b). Increased hydrophilicity on modSLA surface indicated by complete 
dispersion of water drop (b, no measurable contact angle between water drop and 
surface); however, no dispersion of water drop on hydrophobic SLA surface (a, obvious 
measurable contact angle between water drop and surface).45 
 
 
Figure 4: The increased surface hydrophilicity can also induce an accelerated covering 
of the implant surface with blood from the peri-implant soft and bone tissue during 
placement of the implant, compared to hydrophobic SLA surfaces, thus accelerating 
the initial implant healing period.45 
 
1.3.8  Titanium Materials Coating 
Bioactive surface coatings of titanium dental implants help to optimise implant stability 
by interacting with natural cascades of osseointegration, to improve peri-implant soft 
tissue integration, and to reduce peri-implantitis by impairing bacterial adhesion to the 
implant surface. Coatings which are used in dental implantology researches nowadays 




1.3.8.1 Hydroxyapatite and Nanocomposite Coating 
Hydroxyapatite (HA) is a very stable biological form of CaP that strengthens the 
organic matrix by mineralization. Biomimetic surface techniques attempt to promote 
osseointegration by integration of a singular component or a combination of these 
elements into the implant surface. 
HA coatings resemble a reservoir of calcium and phosphate
46 
in addition to their 
biomimetic property. For several years, titanium plasma spraying was the commonly 
applied technique to deposit CaP on implant surfaces.
47 
A powder was dispersed into 
a plasma torch that is targeted on the implant resulting in a CaP thickness of 40-50 μm.
48 
Uncertainty exists regarding the long-term stability of plasma-sprayed HA coatings
49 
and long-term clinical outcomes were poor.
50
 
A recently introduced surface treatment generates a hydrophilic monolayer 
of multiphosphonic acid molecules on the outside of the implant surface, thus imitating 
natural hydroxyapatite (SurfLink, Nano Bridging Molecules, Gland, Switzerland).
51
 
To simulate the biological environment of nanoscale crystals in native bone tissue, 
nanotechnology has become of essential importance to compose nanoscale 
hydroxyapatite (nHA) containing implant surfaces.
52
 
Extensive work has been carried out to transfer nanotechnology to HA coatings. nHA is 
used as a single compound coating or as part of a composite in combination with carbon 
nanotubes, collagen, titanium dioxide, bioglass, silica, or ceramic oxide. A major 
advantage of nanocomposites is the ability to adjust the mechanical characteristics of 




1.3.8.2 Growth Factors 
In haemostasis primary phase of osseointegration, platelets, which have been liberated 
to the alveolar bone from damaged vessels, degranulate and release specific growth 
factors that initiate the second phase of osseointegration, the inflammatory phase. These 
factors embrace fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), 
and transforming growth factor beta (TGF-β). Macrophages resemble a second 
important source of growth factors. Upon elimination of cell detritus, these cells release 
VEGF (vascular endothelial growth factor), PDGF, and FGF to initiate the proliferative 
 
22 




Bone morphogenetic proteins (BMPs) were first described in 1965 and contain 
a group of at least 18 growth factors that belong to the TGF-β family.
54 
In vivo, BMPs 
are released from osteoblasts, platelets, and endothelial cells and are deposited into the 
bone matrix until being liberated during socket preparation. BMPs regulate genes for 
collagen, alkaline phosphatase, and osteopontin. BMP2, BMP4, and BMP7 exclusively 
stimulate bone formation. To acquire an adequate yield of BMPs, these proteins have to 




1.3.8.3 Extracellular Matrix Proteins 
In the proliferative phase of osseointegration, fibroblasts are triggered by FGF to secrete 
extracellular matrix proteins like collagen, chondroitin sulfate, fibronectin, vitronectin, 
and other proteoglycans. The extracellular matrix provides crucial guidance for 
osteoprogenitor cells that migrate to the implant via interaction of integrins on the cell 
surface and RGD motifs of fibronectin. Osteoblasts have been proposed to originate 
from subset of mesenchymal stem cells that line minor vessels and are known as 
pericytes. Upon the release of BMP, these cells differentiate into osteoblasts.
53
 
Dental implants coated with extracellular matrix proteins have shown a positive effect 




Peptides are biomolecules composed of short sequences of amino acids. They resemble 
fragments of larger proteins. Particular peptides that facilitate cell adhesion in 
osseointegration or that exert antibacterial effects have been employed to design new 
implant surfaces.  
The RGD peptide, a tripeptide composed of L-arginine, glycine, and L-aspartic acid, is 
an important sequence of extracellular matrix proteins that acts as a binding site for 
integrin receptors in adhesion and migration of osteogenic cells. Broggini et al.
57
 
reported no significant effect of RGD peptide coatings in a minipig model compared to 
SLActive control implants. 
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Human beta defensins (HBDs) are peptides that convey antibacterial effects on 
epithelial borders. In cell experiments, HBDs exhibited biocompatibility and were able 




1.3.8.5 Messenger Molecules 
The remodelling phase succeeds the proliferative phase. Woven bone is transformed 
into load oriented trabecular bone.
53 
In bone remodelling, osteoblasts interact closely with osteoclasts. Sclerostin is one of 
the messenger molecules that mediate the osteoblast-osteoclast interaction. It is secreted 




1.3.8.6 Drug Coatings 
HA coatings have been successfully used as local drug delivery systems.  
Statins inhibit the HMG-CoA reductase and are prescribed in dyslipidaemia. When 
incorporated in the implant surface, statins have been claimed to trigger the local 
liberation of BMPs, thus promoting osseointegration. 
Bisphosphonates are antiresorptive drugs that influence bone metabolism mainly by 
inhibition of osteoclasts. Common indications include metastatic bone disease or 
osteoporosis. Peter et al.
59
 demonstrated in a rat model that implants with a 
Zolendronate containing HA coating yield a higher peri-implant bone density and 
promote increased mechanical fixation. In an osteoporotic rat model, Stadlinger et al.
60 
demonstrated increased BIC and a higher level of bone mineralization of Zolendronate 
loaded implants. 
Tetracycline-HCl functions as an antimicrobial agent capable of killing microorganisms 
that may be present on the contaminated implant surface. It also effectively removes the 
smear layer as well as endotoxins from the implant surface. Further, it inhibits 
collagenase activity, increases cell proliferation as well as attachment and bone healing. 
Tetracycline also enhances blood clot attachment and retention on the implant surface 






Implant coating Example Studies Outcome 
Carbon coating Currently not on the 
market; still not being 
investigated 
In vitro, in vivo, and         




studies are still under way 
Bisphosphonates Currently not on the 
market; still not being 
investigated 
No long-term studies 
available 




Currently not on the 
market; still not being 
investigated 
Pilot animal studies 
and  clinical studies 
Studies are still under way 
Bioactive glasses 
and ceramics 
Currently not on the 
market; still not being 
investigated 
Chemical, in vivo, and 
in vitro studies 
Studies are still under way 




Restore Implant system In vitro, in vivo, and 
retrieval studies  
Most commonly used type 
of implant coating; other 
implant coating studies 
mainly use HA as a control 
Titanium/titanium 
nitride 
IonFusion In vitro, in vivo, and         
clinical studies  
Titanium mechanical 
properties are considered 
in relation to the degree of 
osseointegration 
Table 4: Summary of implant coatings.61 
 
1.4 Biocompatibility and Its Measuring 
Biocompatibility is formally defined as the ability of a material to elicit an appropriate 
biological response in a given application in the body. Inherent in this definition is 
the idea that a single material may not be biologically acceptable in all applications. 
Whether or not a material is biocompatible therefore depends on the physical function 
for which the material will be used and the biological response that will be required 




Measuring the biocompatibility of a material is not simple, and the methods of 
measurement are evolving rapidly as more is known about the interactions between 
dental materials and oral tissues and as technologies for testing improve. Several 
varieties of tests are currently used to ensure that new materials are biologically 




Test Advantages Disadvantages 
In vitro 
tests 
Quick to perform Relevance to in vivo is questionable 





Can be standardised 
Large-scale screening 
Good experimental control 
Excellence for mechanism of interactions 
In vivo tests Allow complex systemic interactions Relevance to use of material is 
questionable 
Response more comprehensive than in vitro 
tests 
Expensive 





Difficult to control 
Difficult to interpret and quantify 





Very time consuming 
Major legal/ethical concerns  
Can be difficult to control 
Difficult to interpret and quantify 
 
Table 5: Advantages and disadvantages of biocompatibility tests.62 
 
1.4.1 In Vitro Evaluation Methods 
Biocompatibility in vitro tests require placement of a material or its component in 
contact with isolated biological system like a cell, enzyme, or other. They are executed 
out of the living organism. This contact can be either direct, when the material contacts 
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the cell system without barriers, or indirect, when there is a barrier of some sort between 
the material and the cell system. Material in the direct tests can be either physically 
present with the cells, or there can be only some extract from the material which 
contacts the cell system. 
In vitro tests are used to measure cytotoxicity or cell growth, metabolic or other cell 
function or the effect on the genetic material in a cell (mutagenesis assays). Often there 
is overlap in what a test measures. 
In vitro tests have many significant advantages compared to other types 
of biocompatibility tests – they are relatively quick, can be standardised, are suitable to 
large-scale screening, and generally cost less than animal tests.  
The major disadvantage of in vitro tests is their questionable relevance to the final in 
vivo use of material. Another significant disadvantage includes the lack of inflammatory 
and other tissue-protective mechanisms in the in vitro environment. It should be pointed 




1.4.1.1 Cells Used for in Vitro Assays 
Standardization of in vitro tests is a primary concern. Two types of cells can be used for 
in vitro assays – primary cells and continuously grown cells (cell lines). 
Primary cells are those cells taken directly from an animal and cultured. These cells will 
grow for only a limited time in culture but usually retain many of the characteristics of 
cells in vivo. For measuring cytotoxicity of materials, primary cell cultures seem to be 
more relevant than continuous cell lines. However, primary cells, being from a single 
individual, have limited genetic variability, may harbour viral or bacterial agents that 




Continuously grown cells or cells lines are cells that have been transformed previously 
to allow them to grow more or less indefinitely in culture. Because of this 
transformation, these cells do not retain all in vivo characteristics, but they do 
consistently exhibit those features that they do retain. Genetic and metabolic stability of 
continuous cell lines contributes significantly toward standardizing assay methods.  
Human foetal osteoblast cell line 1.19 (hFOB 1.19) provides a homogenous, rapidly 
proliferating model system for studying normal human osteoblast differentiation, 
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osteoblast physiology, and hormonal, growth factor, and other cytokine effects on 
osteoblast function and differentiation.
64
 Immortalized human gingival fibroblasts 
(hTERT) play important role in testing the biocompatibility and toxicity of new dental 
materials.
65 
Finally, both primary and continuous cells play an important role in in vitro testing; and 
both should be used to assess materials.
 
 
1.4.1.2 Cell Adhesion to Implantable Material 
After implantation, the fate of the implant surface has been described as a “race for 
the surface” among protein adsorption, host cell adhesion, and bacterial adhesion.
66
 
The first step a cell has to take to be able to differentiate and express its potential is 
often adhesion on a substrate, whatever this one might be. This adhesion or attachment 
of the cell occurs through specific structures, such as hemidesmosomes and focal 
adhesions. Specific protein structures (receptors) such as integrins in focal adhesions 
and cadherins in hemidesmosomes allow this attachment.
67 
Different treatments for different biomaterials have been proposed to enhance the 
properties of the surface of these biomaterials to promote cellular adhesion. 
Cell–matrix adhesions are discretely distributed on the cell surface and mediate cell 
interactions with the ECM. They are essential for cellular functions, such as cell rolling, 
migration, differentiation, tissue remodelling and homeostasis. Mechanical force plays a 
key role in adhesion maturation.  
Throughout the maturation of cell-matrix adhesions, integrins are key players. Integrins 
are a family of transmembrane proteins: the ectodomain of integrin binds to its ECM 
ligands and the cytoplasmic tail links to the cytoskeleton via adaptor molecules 
including talin, actin, vinculin, and tensin, thereby connecting the intracellular 
cytoskeletons to the ECM through the adhesion sites and transmitting bidirectional 









Figure 5: Interconnection of intra- and extracellular proteins.69 
 
1.4.1.3 Immunocytochemistry 
Immunocytochemistry (ICC) is a common laboratory technique where a specific 
primary antibody is used to bind on a specific protein or antigen in cells in order to 
visualize the localization of such a protein or antigen. The primary antibody allows 
visualization under fluorescence microscope when it is bound by a secondary antibody 
which has a conjugated fluorophore. ICC allows for the evaluation whether or not cells 
in a particular sample express the antigen. In cases where an immunopositive signal is 
found, ICC is also able to determine which sub-cellular compartments are expressing 
the antigen. 
 
1.4.1.4 Cell Viability and Proliferation 
Cell-based assays are often used to determine if the test molecules have effects on cell 
proliferation or show direct cytotoxic effects that eventually lead to cell death. These 
assays are also helpful for measuring receptor binding and a variety of signal 
transduction events that may involve the expression of genetic reporters, monitoring 
organelle function, or trafficking of cellular components. Indifferent to the type of 
cell-based assay being used, it is substantial to know the amount of viable cells which 
remained at the end of the experiment.
70
 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is 
based on the conversion of MTT into formazan crystals by living cells, which 
determines mitochondrial activity. Since for most cell populations the total 
mitochondrial activity is related to the number of viable cells, this assay is widely 
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used to measure the in vitro cytotoxic effects of drugs on cell lines or primary patient 
cells.
71
 The MTT assay was the first homogeneous cell viability assay developed for a 
96-well format that was suitable for high throughput screening (HTS). The MTT assay 
technology has been widely adopted and remains popular in academic labs as evidenced 
by thousands of published articles. The MTT substrate is prepared in a physiologically 
balanced solution, added to cells in culture, usually at a final concentration of 0.2-0.5 
mg/ml, and incubated for one to four hours. The quantity of formazan (presumably 
directly proportional to the number of viable cells) is measured by recording changes in 
absorbance at 570 nm using a plate reading spectrophotometer. A reference wavelength 
of 630 nm is sometimes used, but not necessary for most assay conditions. 
Viable cells with active metabolism convert MTT into a purple coloured formazan 
product with an absorbance maximum near 570 nm. When cells die, they lose the ability 
to convert MTT into formazan, thus colour formation serves as a useful and convenient 
marker of only the viable cells. The exact cellular mechanism of MTT reduction into 
formazan is not well understood, but likely involves reaction with NADH or similar 
reducing molecules that transfer electrons to MTT.
70 
 
Figure 6: Transformation of MTT to formazan by living cells.70 
 
The formazan product of the MTT tetrazolium accumulates as an insoluble precipitate 
inside cells as well as being deposited near the cell surface and in the culture medium. 
The formazan must be solubilized prior to recording absorbance readings. A variety of 
methods have been used to solubilize the formazan product, stabilize the colour, avoid 
evaporation, and reduce interference by phenol red and other culture medium 
components. Various solubilisation methods include using: acidified isopropanol, 
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DMSO, dimethylformamide, SDS, and combinations of detergent and organic solvent. 
Acidification of the solubilizing solution has the benefit of changing the colour of 
phenol red to yellow colour that may have less interference with absorbance readings. 




1.4.2 In Vivo Evaluation Method 
Goal of in vivo evaluation methods is to determine biocompatibility or safety in a 
biological environment. The tests are carried out to determine that the device performs 
as intended and presents no significant harm to patient or user. In vivo evaluation 
involves implanting a sample of the material in test animals. The geometry of the test 
sample should simulate that of the implant device. Surface textures and relative size 
should be similar. If there is a possibility of wear debris in adjacent tissue, the particles 
of the material similar in size and shape to wear debris should be implanted with 
implant specimen. The implant specimen may be placed in muscle or cortical bone. 
 
1.4.2.1 Osseointegration 
Osseointegration is defined as a direct connection between living bone and a 
load-carrying endosseous implant at the light microscopic level
72 
or as a time-dependent 
healing process whereby clinically asymptomatic rigid fixation of alloplastic materials 
is achieved, and maintained, in bone during functional loading.
73
 
Direct bone healing, as it occurs in defects, primary fracture healing and in 
osseointegration, is activated by any lesion of the pre-existing bone matrix. 
When the matrix is exposed to extracellular fluid, non-collagenous proteins and growth 
factors are set free and activate bone repair. Once activated, osseointegration follows 
a common, biologically determined program that is subdivided into three stages: 
1) incorporation by woven bone formation; 
2) adaptation of bone mass to load (lamellar and parallel-fibred bone deposition); 
3) adaptation of bone structure to load (bone remodelling).74 
 
Osseointegration requires primary stability, enabling bone progenitor cells from the 
existing bone or bone marrow to deposit new bone matrix around the implant material. 
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The implant integration into the bone tissue provides biomechanical stability and 
enables load-bearing. 
 
1.4.2.2 Bone-Implant Contact (BIC) 
Although the definition of osseointegration does not state the proportion of bone in 
contact with the implant surface, one of the most used variables in histomorphometric 
analysis of implants is the fraction of surface areas of mineralized bone in contact with 
the implant surface; so called bone-implant contact (BIC).  
Histomorphometry is an established method to determine the extent of osseointegration 
and the rate of healing of dental implants; it can be used to measure the percentage of 
BIC. 
Implant ground sections in situ are relatively thick sections (20-40 µm) and therefore 
only a few sections are obtainable from a bone-implant block. When serial sections of 




Experimental trials on animal models revealed that implants with roughened surfaces 
had a better early anchorage in bone tissue and a higher percentage of BIC than implants 
with smooth surfaces.
76,77 
Repeating the same experiments in human studies produced 
the same results.
78-81
 The successful clinical use of micro-rough titanium implant 
surfaces have laid the foundations for developing further surface topographies to 






2 Aim and Objectives 
 
The aim of the first study was to measure cell adhesion and viability on the titanium and 
nanostructured titanium surfaces of dental implants and to evaluate if any of the six 
studied materials is better than others with respect to biocompatibility and cell 
proliferation. 
Examined samples of titanium had grain sizes of 160 nm, 280 nm, and 2,400 nm. For 
each grain size there were two types of sample: cross-section (−) and longitudinal 
section (+). 
Hypotheses: 
1) grain size influences strength of material as well as its interactions with cells; 
2) the smaller grains, the better biocompatibility (incl. wettability, cell adhesion and 
proliferation) and cell viability; 
3) different sections differ in viability of cells grown on its surface – crystallographic 
texture is more important than grain sizes; 
4) all tested materials are cytocompatible. 
 
The fundamental aim of the second study was to review the experimental methods 
currently being used to evaluate the osseointegration of nanostructured titanium 
implants using animal models, to illustrate and compare the results of histological 
staining methods used in dental implantology and, finally, to develop and demonstrate a 
standardized and reproducible technique for stereological quantification of bone-implant 
contact. It was also expected to collect practical knowledge useful for further 
examinations. 
In this study, dental implants with various surface modifications were used, as e.g., 
laser-treated, acid-etched, plasma-coated, and sand-blasted surface. Animal species and 
target bones were carefully compared in terms of the ratio of compact to spongy bone.  
Hypotheses: 
1) surface modifications play a very important role in biocompatibility and 
osseointegration; 
2) mechanically added surface roughness significantly increases the contact area 
between the implant surface and the peri-implant bone.  
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3 Experimental Work 
 
3.1 Comparison of Fibroblast and Osteoblast 
Response to Cultivation on Titanium Implants 
with Different Grain Sizes 
 
3.1.1  Titanium  
All the samples were obtained from commercially pure titanium by the ECA pressing 
method from cpTi grade 2. They have a cylinder shape with a diameter of 4.98-5.05 mm 
and height of 2.93-3.01 mm (Figures 7a and 7b). Used samples of titanium have grain 
sizes of 160 nm, 280 nm, and 2,400 nm. For each grain size there were two types of 




Figure 7: Photographs illustrating nanostructured titanium samples (a – macroscopic 
image; b – details of the surface; c – SEM images of longitudinal cross-section; d – SEM 
images of transversal cross-section). 
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Each implant was cleaned and sterilised before usage. The procedure contains 
incubation in a trypsin solution (0.25% (w/v) Trypsin-0,53 nM EDTA solution, PAA 
Laboratories GmbH, Austria) (30 minutes, 37 °C), followed by incubation in an 
ultrasonic bath (20 minutes, 25 °C), incubation in acetone (20 minutes, 25 °C), and at 
the end rinse in 70% ethanol and deionised water. Finally the implants were sterilised by 
autoclaving. 
 
3.1.2  Surface Roughness Measuring Method 
The surface roughness of each sample was measured three times using a mechanical 
contact profilometer Surtronic 25 (Taylor Hobson, UK). Surface roughness of samples 
was quantified by arithmetical mean roughness Ra (defined as arithmetic average 
of the absolute values of the profile height deviations from the mean line) and ten-point 
mean roughness Rz (defined as the sum of the average value of absolute values of the 
heights of five highest profile peaks and the depths of five deepest profile valleys 
measured in the vertical magnification direction from the mean line). The surface 
roughness was measured at a traverse speed of 1 mm/s with a diamond-tipped stylus 
with 5 µm radius. The average of the three measurements was recorded as the mean 
surface roughness for each specimen. 
 
3.1.3  Viability and Proliferation Measuring Method 
Cell Cultures 
Both used cell lines were obtained from ATCC (American type culture collection, 
Rockville, MD, USA) and cultured in accordance with ATCC recommendations. 
Culture media were refreshed as needed. Human foetal lung fibroblasts (HFL1, ATCC, 
and CCL153) were cultivated in F12K Medium (PAA Laboratories GmbH, Austria) 
supplemented with 10% (v/v) foetal bovine serum (FBS, PAA Laboratories GmbH, 
Austria), 100 U/mL penicillin and 100 mg/mL streptomycin (PAA Laboratories GmbH, 
Austria), and 2.5 mML-glutamine (Gibco, Life Technologies, Paisley, UK) at 37 °C 
under 5% CO2 in a humidified incubator. 
A human foetal osteoblast cell line, hFOB 1.19 (ATCC, CRL11372), established 
by Harris et al., was grown in a 1:1 mixture of Ham’s F12 Medium and 
Dulbecco’s Modified Eagle’s Medium with 2.5 mML-glutamine (without phenol red) 
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(Gibco, Life Technologies, Paisley, UK) supplemented with 10% (v/v) FBS and 
0.3 mg/mL geneticin (G418, Serva Electrophoresis GmbH, Heidelberg, Germany). 
Cells were maintained at 34 °C under 5% CO2 in a humidified incubator. 
Cell Viability and Proliferation 
Cell proliferation after 48 hours from plating was assessed by MTT viability and 
proliferation assay (ScienCellTMResearch Laboratories, Carlsbad, CA, USA) according 
to the manufacturer’s instruction. This assay is based on the conversion of pale yellow 
tetrazolium MTT to purple formazan crystals, which can be solubilised and then 
spectrophotometrically quantified. 
The samples of implants were placed into a 96-well plate (TPP, St. Louis, MO, USA). 
Cells harvested with trypsin solution from Petri dishes were resuspended in culture 
medium and seeded at a density of approximately 500,000 cells/mL onto the top 
of the discs of nanostructured titanium in 20 𝜇L volume. As positive control, cells 
grown directly on the 96-well tissue culture plate were used. 
After 48-hour incubation, cells were washed with phosphate-buffered saline (PBS) and 
incubated with 10 𝜇L MTT (25 mg/mL) solution at 37 °C. After 4 hours, 
100 𝜇L of MTT solubilisation buffer (equal to the volume of original culture medium) 
was added to each well and the insoluble formazan formed was dissolved by pipetting 
up and down. 
The absorbance was measured at 570 nm (spectrophotometer Nano Drop 1000, Thermo 
Fisher Scientific, Waltham, MA, USA), subtracting the background absorbance 
determined at 690 nm. 
 
3.1.4  Fluorescence Microscopy 
Cells Staining 
Cultured cells were stained with CellTracker Green 5-chloromethylfluorescein diacetate 
(CMFDA) (Molecular Probes, Inc., Eugene, Oregon, USA) according to 
the manufacturer’s instruction. Briefly, cells were properly washed with PBS and 
incubated with 4 𝜇M CMFDA working solution for 30 minutes at 37 °C. Then, the dye 
working solution was replaced with fresh, prewarmed medium and the cells were 
incubated for another 30 minutes at 37 °C. Stained cells were analysed using an 




The initial cell attachment and the spreading of the cells on the substrate with different 
grain size were examined after 6 and 24 hours, respectively. The area occupied by the 
cells was assessed by analysis of gained images by the programme ImageJ (W. S. 
Rasband, U. S. National Institutes of Health, Bethesda, Maryland, USA). 
Immunocytochemistry 
The samples of implants were placed into a 24-well plate. Five hundred cells were 
seeded onto the top of the discs of nanostructured titanium cells and incubated for 2 or 
48 hours. Fixation was performed by 3% formaldehyde in PBS for 15 minutes at 37 °C 
followed by three rinses with PBS. Permeabilisation was carried out by incubation with 
0.1% triton X-100 solution in PBS for 10 minutes at room temperature. Blocking with 
2% normal goat serum (Milipore, Billerica, MA, USA) followed for 1 hour at 4 °C. 
Each sample was double stained. Indirect immunofluorescence staining was done with a 
mouse monoclonal antivinculin antibody hVIN-1 diluted in PBS (1:100) and goat 𝛼-
mouse Atto488 conjugated secondary antibody. For actin staining, Phaloidin-
Tetramethylrhodamine B isothiocyanate (TRITC) was added into the solution of 
secondary antibody in PBS (0.75 Atto488 : 1.5 TRITC : 100 PBS) (all Sigma–Aldrich, 
St. Louis, MO, USA). Incubation with primary antibody was overnight. The second 
incubation was 2 hours at room temperature in the dark. Samples were analysed using 
an Olympus IX 70 fluorescent microscope equipped with a Cell R system at 40x, 100x, 
and 400x magnification. 
 
3.1.5  Statistical Analysis 
Microscopic analysis was carried out two times at a minimum, using two samples per 
group. In case of MTT assay, two independent experiments with quadruplicate 
measurements were performed. Cell viability was compared by analysis of variance 
(ANOVA). If ANOVA indicated a significant difference (𝑃 < 0.05) statistical 
comparisons were computed by two-tailed unpaired t-test with the value of significance 
𝑃 < 0.05. Statistical analysis was performed using the SigmaPlot 12.5 software (Systat 





3.1.6  Results 
3.1.6.1 Sample Characterization 
Sample characterization was performed by SEM. Figure 8 shows SEM images 
of the titanium sample surfaces. The surface roughness quantified by arithmetical mean 
roughness Ra and ten-point mean roughness Rz of each sample is shown in Figure 9. 
Values of Ra were between 0.3 and 0.6 𝜇m and Rz between 1.5 and 3.0 𝜇m. We did not 
find any significant differences in surface roughness (for both parameters Ra and Rz) 




Figure 8: SEM photographs of the sample surfaces with different grain sizes and 
sections (a, b, c – SEM images of longitudinal cross-section with grain sizes of 160, 280, 
and 2,400 nm, respectively; d, e, f – SEM images of transversal cross-section with grain 





Figure 9: The surface roughness expressed by arithmetical mean roughness Ra and 
ten-point mean roughness Rz. The standard errors were calculated from three 
independent measurements. Error bars indicate means ± standard deviations. 
 
3.1.6.2 Cell Viability and Proliferation 
Cell Adherence and Spreading 
The initial cell attachment within the first 6 hours was significantly slower on titanium 
materials with grain size 2,400 (− and +) nm and 280 (− and +) nm, when compared 
with control (tissue culture plate) (𝑃 = 0.0043) (Figures 10, 11a, and 11c). On the 
surface with 160 (− and +) nm grains. The cells adhered as well as on control plate. The 
area occupied by fibroblasts on all studied materials reached very similar values as the 
control at 24 hours of cultivation (Figures 10, 11b, and 11d. 
We also analysed differences between particular materials. The occupied area after 6 
hours was significantly higher on material 160− in contrast to 280− and both types of 





Figure 10: The area of surface (percentage) of six studied titanium materials with 
different rain sizes and sections occupied by human fibroblasts HFL1 at 6 hours and 4 
hours after plating. Results from two distinct experiments on the basis of duplicate 
determination were combined. Error bars indicate means ± standard deviations. 
 
 
Microscopic observation revealed that after 6 hours, fibroblasts presented a mainly 
rounded morphology (Figures 11a and 11c). After 24 hours the cells elongated and 
presented a mainly spindle-like structure. On the tissue culture plastic, we did not see 
any specific orientation (Figure 11d. However, on material samples the cells were 




Figure 11: Fluorescence photographs of human fibroblasts HFL1 on tested titanium 




The viability of two cell lines (hFOB 1.19, HFL1) was estimated by MTT assay (Figure 
12). The viability of fibroblasts growing on materials 160−, 280+, and 2,400+ was 
significantly lower than on control plates (𝑃 = 0.026). The osteoblast viability was 
lower, when growing on all types of studied titanium materials with the exception of 
160+ material in comparison with the control (𝑃 < 0.0001). 
The medians of viability of the cells (% of positive control) are shown in Table 6. We 
found higher viability of osteoblasts comparing materials 280− with 160+ and 2,400+ 
with 160+ (𝑃 = 0.0162, 𝑃 = 0.0372; resp.). The comparison of other pairs of materials 
did not exhibit any significant differences. 
On the other hand, material 160+ was a significantly better substrate for culturing 






Material Cross-section Longitudinal section 
160- 280- 2400- 160+ 280+ 2400+ 
hFOB 1.19 72.2 62.2 68.5 91.5 62.3 62.3 
HFL1 68.1 71.4 77.5 77.8 71.5 73.4 
 
Table 6: Medians of viability of two cell lines (hFOB 1.19, HFL1) estimated by MTT 
assay expressed as % of positive control. 
 
Figure 12: Comparison of the viability assessed by MTT assay of human fibroblasts 
HFL1 and human foetal osteoblast cell line, hFOB 1.19 grown on six studied titanium 
materials with different grain sizes. The standard errors were calculated from a 
combination of two independent experiments with quadruplicate measurements. Data 
expressed as % of positive control. Error bars indicate means ± standard deviations. 
 
Immunocytochemistry 
In order to compare morphology of the cytoskeleton, fibroblastic cells grown on the six 
different titanium materials underwent actin labelling with TRITC conjugated phalloidin 
and vinculin labelling with goat 𝛼-mouse Atto488 conjugated secondary antibody for 
mouse monoclonal anti-human vinculin antibody hVIN-1 (Figure 13). 
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Two hours after seeding, cytoskeleton analysis showed that cells presented a round 
shape and were not yet spread properly on the surfaces. On all tested materials, at this 
point of time, focal contacts could be seen as positive spots localised at the cellular 
edge. 
After 48 hours, the cytoskeleton analysis mainly showed cells with an elongated bipolar 
morphology. On all tested surfaces, vinculin-positive focal contacts were present 
homogenously on the whole cell surface, with a slightly higher density at the cell 
periphery, at the ends of F-actin filaments. These data denote that the adhesion phase 
occurred on all tested materials. 
 
3.1.7  Discussion 
In our work, we examined how grain size of nanostructured titanium material influences 
the behaviour of fibroblastic as well as osteoblastic cells grown on its surface. 
The grain size was shown to be an important factor that influenced not only the strength 
of material but also its interactions with cells. Kim et al. proved that the ultrafine grain 
titanium prepared by the ECAP method had better biocompatibility concerning 
wettability, cell adhesion, and proliferation of mouse fibroblasts. Our results did not 
clearly prove that grain size has a distinct impact on viability or proliferation of used 
fibroblast model (HFL1). The only differences we saw were related to the initial phase 
of attachment, but until 24 hours after seeding, differences almost disappeared. Faster 
cell attachment on material with the smallest grain size was observed. 
The metabolic activity, assessed by MTT test, of the cells grown on 160−, 280+, and 
2400+ titanium was significantly decreased against control. However, the tested 
materials did not differ among each other, which indicated that all tested materials were 
cytocompatible. This is in line with the numerous studies demonstrating the 
biocompatible character of titanium as a substrate for cell culturing. 
The usage of a second cell model (hFOB 1.19) revealed that one of the tested materials 
seems to be as good as control with respect to metabolic activity of the osteoblasts 
cultured on its surface. It was the material with the smallest grain size that seemed to be 
consistent with the studies that detected that the smaller the grain size, the better the 
viability. 
Other studied materials were significantly worse than control and 160+. Interestingly, 
this result was reached only for one of two materials with one certain grain size. This 
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observation indicated that two different sections differ in the viability of cells grown on 
its surface, which is in agreement with the study of Hoseini et al., who conclude that 
crystallographic texture, rather than grain size, plays a principal role in the surface 
biocompatibility. 
It is well established that the proteins of extracellular matrix, membrane receptors, and 
cytoskeletal proteins are responsible for cell-substrate interactions. That is why we 
decided to analyse two important cytoskeletal proteins actin and vinculin by 
immunocytochemical staining. Actin is a critical player in many cellular functions, such 
as cell motility and the maintenance of cell shape and polarity. Vinculin is a cytoplasmic 
actin-binding protein enriched in focal adhesions and adherens junctions required for 
strong cell adhesion. As early as 2 hours after seeding, the cells adhered and began to 
spread (Figure 13a). The cells displayed well spreading morphology with many vinculin 
spots after 24 hours (Figure 13b). This observation proved that the adhesion phase 
occurred on all tested materials. We also intend to examine differences between two 
used cell models. Fibroblasts represent soft tissue and osteoblast hard tissue, and the 
dental implant needs to be in contact with both. We did not record significant 
differences in viability among tested materials plating with fibroblast cells. When we 
used osteoblasts as a cell model, we recorded that material with a grain size 160 nm 
with longitudinal section seemed to be as good as a conventional culture plate with 
respect to cell viability and proliferation. Therefore, this material could be 




Figure 13: Visualisation of focal adhesion and cytoskeleton of human fibroblasts HFL1 
on tested titanium material after 2 hours (a) and 48 hours (b) of seeding. Actin 




3.2 Evaluating the Osseointegration 
of  Nanostructured Titanium Implants in Animal 
Models 
Animals of various species, size, and ages are used for the experimental evaluation 
of osseointegration. No species fulfils all requirements of an ideal model to determine 
an optimal interface between bone and dental implants. However, dog, sheep, goat, pig 
and rabbit models are commonly used to evaluate bone-implant interactions. 
The dog seems to be more promising as animal model for testing bone implant 
materials, but there are increasing ethical issues relating to the use of dogs in medical 
research due to their status as companion animals. 
With regard to bone anatomy, morphology, healing and remodelling, the pig 
demonstrates a good likeness to human bone. However, challenges may be encountered 
in relation to its large size and difficulty in handling. Currently, the development of 
miniature pigs has overcome these problems to some extent. 
The rabbit is the most commonly used animal model. However, this species shows the 
fewest similarities to human bone, and its small size, which also limits the quantity and 
size of inserted implants, is a significant disadvantage. 
The most common bones for implantation are a miniature pig maxilla and a rabbit 
femur. The most frequently used experimental animals, their age/weight (according to 
the primary literature), the bones selected for implantation, and healing time are shown 
in Table 7. 
 








approx. 4 kg    femur 3 weeks 
2.8-3.2 kg   nasal bone 8 weeks 
1-3 months/ 2.68±0.29 kg  femur 1 and 3 months 
6-8 months     femur 3 months 
3.0-3.5 kg             tibia 2 and 4 weeks 
4±1 kg femur 6 and 12 weeks 






4 years/ 70-90 kg maxilla 8 weeks 
2-4 years maxilla 1, 2, 4 and 8 weeks 
1 year/ mean weight 60 
kg 
maxilla 4 and 8 weeks 
Pig 18 months calvaria 1, 2 and 4 weeks 
 
Table 7: Animals, bones and healing time in recent studies on osseointegration of 
implants. As some of the studies do not provide details on animal age and size 
consistently, both values are included in the second column. 
 
3.2.1 Titanium and Nanostructured Titanium 
Titanium and its alloys are commonly used as biomaterials for both dental and 
orthopaedic implants due to their advantageous properties, including biocompatibility, 
nontoxicity, high specific strength, and corrosion resistance. Whilst commercially pure 
titanium has sufficient biocompatibility but relatively poor strength, titanium alloys 
have superior strength but contain potentially toxic or allergenic ingredients.  
Because of their positive properties, such as the easy formation of a stable oxide, high 
corrosion resistance, and fast passivation, titanium and its alloys were among the first 
metals to be used for the manufacture of medical implants. The long-term stability 
of titanium implants depends on establishing direct bone-implant contact (BIC) without 
a fibrous connective tissue interface. Loosening or failure of the implant can be caused 
by inflammation and bone resorption induced by wear debris in the form of titanium 
particles from the implant that enter into the surrounding tissues. Therefore, it is 
essential to improve the biocompatibility and wear resistance of a titanium implant for 
its successful long-term survival. 
 
3.2.2 Animal Species and Bones 
Animals of various species, size, and ages are used for the experimental evaluation 
of osseointegration. No species fulfils all requirements of an ideal model to determine 
an optimal interface between bone and dental implants. However, dog, sheep, goat, pig 
and rabbit models are commonly used to evaluate bone-implant interactions. 
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The dog seems to be more promising as animal model for testing bone implant 
materials, but there are increasing ethical issues relating to the use of dogs in medical 
research due to their status as companion animals. 
With regard to bone anatomy, morphology, healing and remodelling, the pig 
demonstrates a good likeness to human bone. However, challenges may be encountered 
in relation to its large size and difficulty in handling. Currently, the development of 
miniature pigs has overcome these problems to some extent. 
The rabbit is the most commonly used animal model. However, this species shows the 
fewest similarities to human bone, and its small size, which also limits the quantity and 
size of inserted implants, is a significant disadvantage. 
The most common bones for implantation are a miniature pig maxilla and a rabbit 
femur. The most frequently used experimental animals, their age/weight (according to 
the primary literature), the bones selected for implantation, and healing time are shown 
in Table 7. 
 
3.2.3 Methods of Implantation into Compact and Spongy 
Bone 
Selecting the target bone is an important step of the study design. For example, implants 
intended to be used in human maxilla may be tested in porcine maxilla. The maxilla has 
a variable layer of compact cortical bone on the surface, below which mostly spongy 
bone is found. However, both porcine and human mandibles have a substantially greater 
proportion of very thick compact bone. The average buccal cortical thicknesses are 1.69 
mm (molar region), 1.43 mm (premolar region), and 1.04 mm (anterior region) in the 
edentulous maxilla and 2.06 mm (molar region), 1.78 mm (premolar region), and 1.36 
mm (anterior region) in the edentulous mandible. Changes in the relative composition 
between trabecular and cortical bone in atrophic edentulous mandibles are due to loss of 
height and total area, mainly at the expense of trabecular bone, but not to changes in the 
cortical bone. Due to a different spatial organization of the compact and spongy bone, 
the choice of implant location might result in various values of the BIC parameter, 
which is the most widely used quantitative parameter for evaluating osseointegration 
(see below for details on BIC quantification). Moreover, different proximal vs. distal 
segments of long bones, such as the femur, tibia, and humerus (Table 7), may vary in 
the proportions of compact and spongy bones. Again, variable proportions of compact 
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and spongy bone tissue within the same anatomical bone could represent a possible 
source of bias. Whilst implants (or their parts) fully embedded within the compact bone 
could theoretically reach maximum values of BIC, parts of implants surrounded by 
spongy tissue will always be partially touching other types of tissue between the bone 
trabeculae, such as connective tissue or bone marrow. This will inevitably result in 
lower BIC parameter values. To prevent any significant bias, we suggest that studies on 
implant osseointegration should be accompanied by details on the ratio between 
compact and spongy bone at the site of implantation. Unfortunately, these values are 
rarely found in the literature. The cortical thickness of rabbit femoral proximal diaphysis 
is 9.5±0.4 mm. 
 
3.2.4  ISO Standards in Implant Testing 
The results of an experimental evaluation of osseointegration should be compatible with 
ISO Standards (ISO 10993-6 Biological evaluation of medical devices – Part 6: Tests 
for local effects after implantation), and several recommendations should be considered 
(ISO 10993-6, 2014) during the design of the experiment, as follows:  
1) the diameter of the dental implant should be between 2 and 4.5 mm;  
2) when using rabbit as an animal model, the maximum number of implants per 
animal is 6; and  
3) when using a pig as a model, the number of implants per animal must not exceed 
12.  
 
3.2.5 In Vivo Evaluation 
In an in vivo evaluation, animals are used to test the effect of various biological entities 
as well as to observe the overall effect of an experiment on a living subject. Under 
general anaesthesia and standard disinfection and aseptic conditions, skin incision and 
soft tissue preparation will be performed, and a mucoperiosteal flap will be incised and 
raised to expose the entire extent of the bone where the implants are to be placed. After 
bone exposure and surgical preparation of the bone, the implant will be inserted (Figure 
14A) It is essential to use copious amounts of sterile saline irrigation and sharp drills to 
prevent heating the bone above 47 °C, which could result in bone cell death and 
osseointegration failure. The insertion technique depends largely on the implant system 
being used. Wounds will be closed primarily layer by layer from deep to superficial 
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tissue with resorbable suture material after thorough cleaning and irrigation. Following 
the surgical insertion of an implant in the animal and post-operative care, the animal is 
allowed to mature and will then be sacrificed. During the period of healing and 
osseointegration, it is possible to perform radiographic examinations, such as X-ray, CT 
or densitometry analysis, to track the healing progress and determine the exact position 
of the implants (Figure 14B) After sacrificing the animal and separating the bone 
containing the implants from the soft tissue, other radiographic images will be taken for 
analysis (Figure 14C).  
 
 
Figure 14: A – Implants inserted into the pig mandible, B – X-ray of rabbit femur 2 
weeks after surgery, C – X-ray of rabbit femur 12 weeks after surgery (shortly after the 
animal has been euthanized). 
 
In general, handling wild animals during experiments is difficult, and complications 
may occur at any time. At the time of surgery, the animal can be lost due to the 
introduction of intratracheal intubation during general anaesthesia. Infection of the 
wound, which is a common postoperative complication, may develop because 
maintaining animals in a hygienic environment is extremely challenging (Figure 
15A,B,C). Based on our experience, the utilization of young animals for experiments 
may bring another complication. Radiographic images have revealed the occurrence of 
opposition of bone above the implant head due to osteoblastic activity, and the largest 
part of the implant shifted inside the bone marrow cavity due to the osteoclastic activity 
of osteoclasts. This led to resorption of bone at the distal part of implant because of the 





Figure 15: Postoperative inflammatory complication (A – Rejected implant due to 
inflammation, B – rejected implant after explantation, C – X-ray of inflamed bone). 
 
3.2.6  Histologic Processing of Implants  
3.2.6.1 Harvesting the Samples 
At the end of the experiment, tissue samples are harvested from the animals and 
processed. The anatomical position and orientation of implants in bone should be 
verified using X-rays. This is also very helpful for subsequent cutting of bones into 
smaller tissue blocks of bone with implants. A suitable tissue-block size for histological 
processing depends on the size of the implants or the size of formed defects during the 
evaluation of degradable osteoinductive biomaterial. The tissue block should be as small 
as possible for better penetration of fixation fluid. However, at least two millimetres of 
bone tissue surrounding the implant should be preserved to allow for a reliable 
evaluation of osseointegration. Therefore, tissue blocks exceeding 2×2×2 cm are cut 
using either a diamond band saw (Figure 16A) or a special low speed diamond wheel 
saw. The orientation of the tissue blocks relative to the original anatomical positions 
should be marked and carefully maintained during all processing steps. Further 
processing might differ in samples of surrounding bone without implants (in this case, 
the samples may be decalcified), or in samples with implants (undemineralized 
samples). 
 
3.2.6.2 Undemineralized Ground Sections 
There are methods for processing hard tissue, and for the evaluation of osseointegration 
of titanium implants, a resin and cutting-grinding system is suitable. This method 
provides information on the formation and mineralization of a new bone matrix adjacent 
to the implant. 
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Fixation and Dehydration 
The time of fixation in a 10% formaldehyde solution depends on the sample thickness. 
Tissue blocks 2-4 mm thick require approximately 12 hours for penetration. Slightly 
thicker samples require approximately 24 hours, but some researchers recommend up to 
5 days for 16 mm thick samples. An important factor affecting the fixation time is the 
ratio of spongy bone (with relatively easy fixation) to compact bone (which requires a 
longer fixation time). The samples are then dehydrated in ascending grades of alcohol of 
70%, 80%, 96%, and 100% (two days required per grade of alcohol). After the 100% 
alcohol treatment, the samples are transferred to a 1:1  
Embedding 
Methacrylate-based resins are currently the most commonly used embedding media. 
The time required for dehydration and saturation by resin can be shortened using an 
automatic embedding device with an agitation and vacuum system. The samples are put 
in methyl methacrylate (MMA) without an initiator of polymerization for approximately 
four days. The samples are then put in a mould with resin, and the polymerization of 
resin is initiated either by blue/ultraviolet light or peroxide. A plastic block is formed 
(Figure 16B). Another resin frequently used for embedding is epoxy resin (e.g., Epon). 
When using epoxy-based embedding resins, after dehydration, the samples are put into 
100% propylene oxide twice for 15 minutes, followed by a 1:1 mixture of propylene 
oxide and Epon overnight and then into clean Epon for two days at 37 °C. Verifying the 
position of an implant in a plastic block with an X-ray might be necessary in non-
transparent resins. 
Sectioning 
The blocks of samples are sectioned along the long axis in the middle of the implants to 
form two blocks. The sample can be cut with a diamond saw band (Exact Apparatebau, 
Norderstedt, Germany), a diamond disc (Figure 16C) (Struers, Ballerup, Hovedstaden, 
Denmark) or a special saw microtome. The cutting area is ground by P1200 grit 
sandpaper until the all tissue segments for observation are exposed to the surface. After 
grinding, the cutting area is polished with P4000 grit sandpaper. A clean slide is glued 
to the polished side. The second incision is made approximately 100-300 μm from and 




Grinding and Polishing 
The slide with the section is ground using a sequence of abrasive papers (P320, P1200 
and P2500 grit) and polished using P4000 grit sandpaper under water irrigation to 
a final thickness of approximately 50-30 μm. For the final polishing of the surface paper 
coated with a fine cloth and diamond paste with grain roughness 3 μm are used. The 
papers for grinding and polishing are on a rotating desk and the samples are pressed 
towards the desk. 
 
 
Figure 16: Processing of samples (A – Formation of tissue blocks using diamond saw 
band, B – formation of resin blocks, C – diamond disk used for cutting of titanium 
implants along its long axis, D – grinding and polishing of samples). 
 
Staining 
The most commonly used staining method is toluidine blue (Figure 17A). Toluidine 
blue can easily differentiate unmineralized osteoid from fully mineralized bone tissue 
and provides sufficient preservation of morphological details. Basic fuchsine can be 
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used alone (Figure 17C) for staining microporous bone or can be combined with 
toluidine blue. Other staining methods for MMA-embedded samples are shown in 
Table 8. 
MMA-embedded sections can also be stained by immunohistochemistry as described in 
decalcified sections. The sections have to undergo dissolution of the embedding resin 
using 2-methoxyethyl acetate for 24 hours and are then cleaned with ethanol, rehydrated 
using a descending ethanol series, and transferred into distilled water. MMA-embedded 
non-decalcified bone yields a stronger immunostaining reaction compared to decalcified 
bone embedded in paraffin. There is also better preservation of the trabecular bone 
morphology. 







blue pink purplish brown   
von Kossa method red red  black dark brown 
Goldner′s 
trichrome method 
blue-grey orange-red  green purple 
Toluidine blue 
 
blue sky blue  light purple purple 
Levai-Laczko violet blue    bright red light blue 
 
Table 8: Staining methods and their results in ground sections. 
 
3.2.6.3 Demineralized (Decalcified) Histological Sections  
Alternatively, bone samples without metal implants, such as biopsies of bone tissue or 
bone from the regions between the implantation sites, may undergo demineralization. 
This technique may be beneficial for the evaluation of degradable osteoinductive 
biomaterials because it demonstrates organic components of bone, such as osteocalcin; 
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(Figure 17B,E); osteopontin; and type I collagen (Figure 17D). After using a 
decalcification solution, the samples may be processed using a routine histological 
paraffin-embedding technique. The most common decalcifying solution is the neutral 
ethylenediaminetetraacetic (EDTA) acid. Decalcification time depends on the sample 
size. Because the demineralization in EDTA requires approximately 8-10 weeks, 
alternative solutions of acids may be used to accelerate the process. However, some 
of the more aggressive decalcifying solutions, such as formic acid, may damage the 
structure of the tissue, thereby limiting its further evaluation. Moreover, some 
biomaterials are harder than bone and have to remain in a decalcification solution for a 
longer period of time. This can affect the morphology of bone, its dyeability and the 
next evaluation. Unfortunately, osteoinductive materials, such as hydroxyapatite 
granules, may affect the cutting of samples because the material can be harder than bone 
and needs to remain in the decalcification solution for a longer period of time. Some 




Figure 17: Staining methods for bone samples evaluation. A – Sky blue osteoid on the 
surface of bone trabeculae adjacent to titanium implant (toluidine blue stain), B – 
brown osteocalcin in osteoblasts and ECM on decalcified section (anti-osteocalcin 
antibody OCG3 visualized by diaminobenzidine), C – pink blood vessels and osteocyte 
lacunae in bone (basic fuchsine stain), D – red or yellow type I collagen in ECM and 
green type III collagen (picrosirius red stain, polarized light), E – detail of osteocalcin 
staining, F – tetracycline incorporated into newly formed bone visualized as a strong 
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green fluorescence signal; the distance between the two outlines of fluorescence is 
proportional to the bone newly built between the two administrations of tetracycline 
(double tetracycline labelling, confocal fluorescence microscope). 
 
3.2.7  Microscopic Evaluation 
Qualitative Evaluation 
Using the staining methods shown in Table 8, qualitative findings, such as the formation 
of unmineralized osteoid and mineralized tissue, loose connective tissue surrounding 
the implant surface, or the formation of granuloma with excessive vascularization but 
poor mechanical retention, can be obtained. 
Histological Quantification of Bone-Implant Contact 
Quantitative histological techniques are frequently used to demonstrate which part 
of the bone directly binds to fully differentiated bone tissue. The most commonly used 
quantitative parameter for the evaluation of osseointegration is the bone-implant contact 





 ,        (1) 
 
where bone contact (BC) refers to the length of direct contact between the implant 
profile and bone tissue, and interface length (IL) indicates the total length of the implant 
surface projected to the section plane. The BIC is a continuous variable expressed as a 
dimensionless ratio of <0;1>, where BIC=0 denotes no direct contact between implant 
and bone, and BIC=1 theoretically means that the entire implant is fully embedded 
within the bone tissue. Alternatively, BIC is often expressed as a percentage value. 
When quantifying objects of macroscopic size (such as the implant-bone interface) on a 
microscopic scale, an appropriate and unbiased sampling of the microscopic fields of 
view from the entire object has to be performed. Briefly, all parts of the specimen 
should be given the same chance to be sampled with the microscopic fields of view and 
included in the quantification. Selecting a lower objective magnification results in a 
larger field of view but a poor differentiation of the bone-implant interface details. 
Therefore, the magnification should be adjusted according to the amount of detail in a 
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particular study so that an unambiguous identification of that detail is possible. Either 
all the adjacent microscopic fields of view are included (Figure 18A) or for larger 
implants, a systematic uniform sampling of the objective image fields is performed by 
selecting, for example, every second field of view (Figure 18B). 
Delineating the BC and IL lines could be done manually. Alternatively, stereological 
grids and principles of stochastic geometry may be used for this task as follows:  
1) a two-dimensional system of lines with known geometrical properties is randomly 
positioned over the series of calibrated micrographs sampled from the bone-implant 
interface (Figure 18B). The line system consisting of perpendicular equidistant lines 
with randomized orientation is isotropic, i.e., it has the same geometrical properties 
in all directions and does not favour any direction. 
2) The number of intersections between the line system and the profile of the implant 
surface is counted manually. According to the modified stereological Buffon’s 
method, the total number of intersections (orange points in Figure 18C,D) is directly 
proportional to the IL, i.e., implants with more structured and greater surface will 
have more intersections with the testing grid.  
3) By contrast, the number of intersections hitting the profile of the implant surface 
attached to the bone is counted. Again, the total number of these intersections (light 
blue points in Figure 18B) is proportional to the BC. After summing all BC and IL 
points from all microscopic image fields from the same specimen, an average BIC 
value may be calculated as the BC/IL ratio. The total number of points hitting the 
profile of the implant surface should be a minimum of 150. Based on our experience, 
this stereological method is highly reproducible, gives consistent results, does not 





Figure 18: Stereological quantification of the bone-implant contact. A – Sampling of 
image fields (red squares) using a low microscope magnification; all adjacent fields 
showing the implant surface (black) and bone (purple) are taken, B – alternatively, 
every second image field is sampled; especially used when higher magnification with 
small field of view is needed, C – stereological grid randomly positioned over the 
micrograph; intersections between the test lines and the implant surface (orange 
points) and intersections between the implant-bone interface and test lines (light blue 
points), D – the same way evaluation but using a higher magnification; detail of BIC and 
the testing grid is shown in embedded rectangle (the bone has blue colour). 
 
Histological Quantification of Other Bone Characteristics  
Vascularization of the bone adjacent to the implant and the numerical density of 
osteocyte lacunae within the bone may be assessed using the stereological point-
counting technique. The lacunar microporosities (density of osteocytes) may be 
statistically independent from the vascular microporosities (bone vascularization), and 
therefore, both parameters should be regarded as complementary characteristics of bone 
quality.  
Alternatively, the amount of bone tissue formed within a certain time interval in the 
region used for implantation may be quantified using the tetracycline labelling test. 
Briefly, a tetracycline antibiotic is administered at two time points. Due to its relatively 
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short biological half-time but high affinity to the bone tissue, tetracycline incorporates 
into bone tissue formed within a specific period, i.e., 1 to 2 days after administration. 
Using the autofluorescence of the tetracycline the bone formed between the two 
administrations of tetracycline can be visualized using fluorescence microscopy 
of the ground sections (Figure 17F). The width of the bone region between the two lines 
marked with tetracycline is proportional to the bone that forms between the two 
administrations of tetracycline. 
 
3.2.8  Results and Discussion 
Based on results of our experiments, we can conclude that the surface of the implant 
plays a very important role in osseointegration and that mechanically added surface 
roughness significantly increases the contact area between the implant surface and the 
peri-implant bone. It is important to note that there are many physiological and 
pathological influences that can affect the results, and it is vital to repeat the method 
several times to increase the accuracy of the results. 
Implant technology is a rapidly progressing science with frequent production of new 
designs, materials, shapes and surface treatments. Therefore, based on the success of our 
method, we could utilize this method in the future to analyse these new modifications. 
The current method that was used made the evaluation of osseointegration more 
efficient, more accurate and faster. An important area of research involves the creation 
of a 'biomimetic surface', or a surface that closely resembles that of real tissue, which 
would assist in the stimulation and proliferation of bone tissue because it stimulates the 
regularity and dimensions of the bone tissue itself without altering the properties of 
titanium. 
To perform a similar experiment, older animals or miniature pigs that have a slower rate 
of growth are recommended. A histological evaluation of experimental osseointegration 
of dental implants requires a careful choice of experimental animals, bones, and 
implantation sites. Bones with a similar ratio of compact to spongy bone, such as the 
human maxilla and mandible, are preferred. Quantification of the BIC contact may be 
performed using an unbiased stereological method, but an appropriate and fair sampling 





The successful outcome of any implant procedure is mainly dependent on the 
interrelationship of the various components of an equation that includes the following: 
1) Biocompatibility of the implant material, 
2) macroscopic and microscopic nature of the implant surface and designs, 
3) the status of the implant bed in both a health and a morphologic (bone quality) 
context, 
4) the surgical technique itself, 
5) the undisturbed healing phase, 
6) loading conditions. 
 
The challenge confronting the clinician is that these several factors must be controlled 
almost simultaneously, if a predictably successful outcome is to be expected. 
In conclusion, histological evaluation of the experimental osseointegration of dental 
implants requires careful selection of the experimental animals, bones, and implantation 
sites. It is also advisable to use larger animal models and older animals with a slower 
growth rate rather than small or growing experimental animals. Bones with a similar 







In the first experiment, similar cellular behaviour was observed on all studied 
biomaterials. There were differences related to the initial phase of attachment, but not in 
proliferation. 
Furthermore, the results indicate that osteoblasts grow on material with a grain size of 
160 nm with longitudinal section as well as on a conventional culture plate, whereas, for 
other studied materials, we observed decreased viability. This material could be 
recommended for further evaluation with respect to osseointegration in vivo. 
It was proven all tested materials were cytocompatible and that grain size influences 
strength of material as well as its interactions with cells – the smaller grains, the better 
biocompatibility and cell viability. 
Different sections did not significantly differ in viability of cells grown on its surface – 
crystallographic texture is more important than grain sizes - the only differences 
observed were related to the initial phase of attachment, but until 24 hours after seeding, 
differences almost disappeared.  
The second study reviewed current methods used in the experimental evaluation 
of the osseointegration of dental implants. The results of histological staining methods 
used in implantology were illustrated and compared. A standardized and reproducible 
technique for stereological quantification of bone-implant contact was proposed and 
demonstrated. 
It was verified that surface modifications play a very important role in biocompatibility 
and osseointegration and that mechanically added surface roughness significantly 
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